In contrast, mesenchymal markers (CD44, CD10, α‐SMA, FSP1) in rat valves were observed to be significantly higher in the CKD group compared to those of the CTL group, which were largely inhibited by administration of DAPT. The gene discussed is MME; the disease is chronic kidney disease.